Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant ResearchSally Arai, Yoshiko Atsuta, Mukta Arora et al.|Biology of Blood and Marrow Transplantation|2014Cited by 435
Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDSMarcos de Lima, Börje S. Andersson, Betty Pierre et al.|Blood|2004Cited by 422
Comparative Analysis of Calcineurin Inhibitor–Based Methotrexate and Mycophenolate Mofetil–Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic TransplantationSaurabh Chhabra, Betty K. Hamilton, Ying Liu et al.|Biology of Blood and Marrow Transplantation|2018Cited by 51
Tools for the Precision Medicine Era: How to Develop Highly Personalized Treatment Recommendations From Cohort and Registry Data Using Q-LearningElizabeth F. Krakow, Erica E. M. Moodie, Michael Hemmer et al.|American Journal of Epidemiology|2017Cited by 42